CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
TDOC NXTdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03615001
NCT03615001N/ACompleted

Assessing the Performance, Safety and Usability of Our Next Generation T-DOC® NXT Catheter for Performing Urodynamic Studies

Laborie Medical Technologies Inc.·interventional·Posted Aug 3, 2018·Updated Jun 9, 2020

In Brief

A clinical study evaluating TDOC NXT for Incontinence, Urge. Completed, enrolled 20 participants across 1 site.

Detailed Summary

Assessing the Performance, Safety and Usability of our Next Generation T-DOC® NXT Catheter for Performing Urodynamic Studies

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedAug 3, 2018
Enrollment StartJul 18, 2018
Primary CompletionOct 4, 2018
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 7.9 years ago

Interventions

TDOC NXTdevice

Assessing the Performance, Safety and Usability of our Next Generation T-DOC® NXT Catheter for Performing Urodynamic Studies